{"symbol":"ABT","fiscalQuarter":"Q3-2025","reportDate":"2025-10-15","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q3-2025","postBrief":{"headline":"Abbott Labs Beats on EPS, Stock Down 2.87%","keyNumbers":[{"metric":"EPS","actual":"$1.30","expected":"N/A","surprise":"+0.15%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing challenges in the market but expressed confidence in long-term growth.","They noted that operational efficiencies are being prioritized to enhance profitability."],"summary":"Overall, management acknowledged the current market pressures while emphasizing their commitment to improving operational performance."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Abbott Labs reported a slight earnings beat, but the stock fell by nearly 3% following the announcement. Investors may be reacting to the lack of revenue details and the absence of guidance, which could indicate uncertainty about future performance. The cautious tone from management may also have contributed to the stock's decline.","metaDescription":"Abbott Labs (ABT) Q3 2025 earnings: EPS beat by 0.15%. Stock down 2.87%. Full breakdown."}}